[This article is not yet translated to FRE. Showing untranslated version.]
Publisert 05.01.2018
Før jul skrev vi en artikkel basert på Investtechs forskning som viser at januar statistisk sett er en god periode for mindre likvide aksjer og for aksjer med høy volatilitet. Nå er vi i begynnelsen av januar og tar derfor en kikk på hvordan aksjene vi så på før jul, har utviklet seg så langt i år.
Analysene ble skrevet basert på sluttkurs mandag 18. desember, og knapt tre uker senere har de syv omtalte aksjene i gjennomsnitt steget 8,3 prosent. OMX C20 Cap er i samme periode opp 1,3 prosent. Meravkastningen er dermed på 7 prosentpoeng for hele perioden.
Ticker | Kurs 19.12 | Kurs 02.01.2018 | Diff fra 19.12.2017 | Kurs 05.01.2018 | Diff fra 19.12.2017 |
AMBUB | 105,5 | 109,00 | 3,00% | 114,00 | 8,00% |
HH | 130,00 | 145,00 | 12,00% | 155,00 | 19,00% |
VELO | 0,90 | 0,86 | -4,00% | 0,89 | -1,00% |
G4S | 22,04 | 22,02 | 0,00% | 23,09 | 5,00% |
COLUM | 14,20 | 14,80 | 4,00% | 15,70 | 11,00% |
PNDORA | 626,00 | 675,50 | 8,00% | 675,60 | 8,00% |
VWS | 436,60 | 428,80 | -2,00% | 423,90 | -3,00% |
Snitt | 3,80% | 8,30% | |||
OMX C20 Cap | 1138,02 | 1143,41 | 0,50% | 1152,31 | 1,30% |
Investtechs nyttårsraketter for Oslo børs, hadde ved stengetid torsdag 4. januar i snitt steget 10 prosent. Nyttårsrakettene for Stockholmsbørsen har i snitt steget 7,2 prosent.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.